Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fraction
Key result
Rising LVEF correlates with improved clinical outcomes in spironolactone-treated heart failure patients.
Authors
Discussion
Loading...
Member takes
Implication
Encourages EF-stratified spironolactone use in HF; extends randomized evidence for an efficacy gradient across the EF spectrum.
Key Points
- The aim is to evaluate how ejection fraction influences the effectiveness of spironolactone in heart failure patients.
- Observed patients with heart failure and preserved ejection fraction.
- Administered spironolactone as treatment.
- Monitored outcomes related to heart failure.
- Analyzed the impact of ejection fraction on treatment response.
- Identified varying outcomes based on ejection fraction levels.
- Noted improved efficacy of spironolactone in specific ejection fraction ranges.
- Provided insights for tailored treatment approaches.
Cite This Study
Solomon et al. (2015) studied this question. Increasing ejection fraction significantly correlates with improved clinical outcomes in heart failure patients treated with spironolactone.